Corteva, Inc. — 2023 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2023; this is an annual report, not a standalone fourth-quarter report. Corteva is a global agricultural inputs company operating through Seed and Crop Protection. The filing is a combined report with separate statements for Corteva and its subsidiary EIDP; figures below generally refer to consolidated Corteva.
Financial performance
| Metric | 2023 | 2022 | Change / context |
|---|---|---|---|
| Net sales | $17.226 billion | $17.455 billion | Down 1%; volume fell 10%, partly offset by 7% price and 3% portfolio/other gains. |
| Income from continuing operations | $941 million | $1.216 billion | Down 23%; includes higher other expense and interest expense. |
| Net income attributable to Corteva | $735 million | $1.147 billion | Down 36%, including $194 million of discontinued-operations losses in 2023. |
| Diluted EPS | $1.03 | $1.58 | Continuing-operations diluted EPS was $1.30 versus $1.66. |
| Operating EBITDA (non-GAAP) | $3.381 billion | $3.224 billion | Up 5%; price execution and productivity offset volume and cost/currency headwinds. |
| Operating earnings per share (non-GAAP) | $2.69 | $2.67 | Up slightly; excludes specified items and amortization. |
| Operating cash flow—continuing operations | $1.809 billion | $912 million | Improved primarily from receivables and inventory movements. |
| Free cash flow (non-GAAP) | $1.214 billion | $307 million | Operating cash flow less capital expenditures. |
| Cash, cash equivalents and marketable securities | $2.742 billion | $3.315 billion | Year-end balance. |
| Total debt | $2.489 billion | $1.307 billion | Increased following 2023 borrowing and debt issuance. |
Cost of goods sold was $9.920 billion, or 58% of sales, versus $10.436 billion, or 60%, in 2022. Research and development expense rose to $1.337 billion (8% of sales) from $1.216 billion; SG&A was essentially flat at $3.176 billion. Interest expense rose to $233 million from $79 million, mainly due to higher rates, the 2023 notes offering and short-term borrowings. The effective tax rate was 13.9%, compared with 14.7%.
Seed sales increased 5% to $9.472 billion and segment operating EBITDA rose 28% to $2.117 billion; the segment’s EBITDA margin improved about 390 basis points. Crop Protection sales fell 9% to $7.754 billion and segment operating EBITDA declined 18% to $1.374 billion; its margin declined about 215 basis points. The segment EBITDA figures total $3.491 billion before $110 million of corporate expenses, reconciling to company Operating EBITDA of $3.381 billion.
At year-end, current assets were $16.260 billion and current liabilities $10.409 billion. Corteva reported approximately $5.5 billion of available committed and uncommitted credit facilities in the debt note, and separately described approximately $6.0 billion of total unused credit lines. It was in compliance with its debt covenants. The company paid $439 million in common dividends and repurchased $756 million of stock during 2023; management reported approximately $1.2 billion returned to shareholders including dividends and repurchases.
Material changes versus 2022
- Lower sales reflected Crop Protection channel destocking, delayed farmer purchases, strategic product exits, reduced planted area in parts of EMEA and Brazil, and the Russia exit. North American corn acres partly offset these declines.
- Seed pricing and productivity supported stronger Seed earnings, while Crop Protection experienced lower volumes and higher input costs despite pricing and acquisition contributions.
- Cash flow from continuing operations improved substantially, while investing cash outflow increased to $1.987 billion, including $1.456 billion of net cash used for acquisitions.
- On March 1, 2023, Corteva acquired biologicals businesses Stoller and Symborg for approximately $1.590 billion combined. Their contribution to 2023 results was not material, according to the filing.
- Other income (expense) shifted to a $448 million expense from a $60 million expense, reflecting higher foreign-exchange losses, settlement reserves and non-operating pension/OPEB costs.
- Debt rose following issuance of $1.2 billion of senior notes in May 2023; the company issued $600 million at 4.50% due 2026 and $600 million at 4.80% due 2033.
Outlook, management commentary and key risks
For 2024, management expects net sales of $17.4–$17.7 billion, Operating EBITDA of $3.5–$3.7 billion, Operating EPS of $2.70–$2.90, cash from operating activities—continuing operations of $2.1–$2.6 billion, and free cash flow of $1.5–$2.0 billion. Capital expenditures are expected to be approximately $630 million, with about $1.0 billion of share repurchases anticipated. The outlook assumes no extreme weather, major operational disruption, significant customer-demand or payment deterioration, or further acceleration of currency and inflation impacts. Management described agricultural demand as constructive and expects Crop Protection industry conditions to modestly improve as channel inventories rebalance.
The Crop Protection operations restructuring is expected to generate approximately $100 million of annualized savings by 2025. Total expected pretax charges are $410–$460 million, with $90–$120 million of future cash payments; actions are expected to be substantially complete in 2024. Management expects approximately $180–$230 million of net pretax restructuring charges during 2024. The company also recorded $72 million of non-cash accelerated amortization of prepaid royalties in 2023 and estimates approximately $60 million in 2024.
- PFAS and environmental exposure: 2023 discontinued-operations charges were $194 million after tax, primarily related to PFAS settlements and remediation. A $501 million environmental remediation accrual was recorded; disclosed potential exposure above accruals was approximately $655 million. Indemnification and cost-sharing recoveries depend in part on counterparties’ ability to pay.
- Nationwide water settlement: Settling companies funded a $1.185 billion settlement fund in 2023. Final court approval was expected in the first quarter of 2024; opt-outs and approval remain important uncertainties. The filing says the settlement is not an admission of liability.
- Litigation and regulation: The FTC and state attorneys general antitrust case, related private litigation, Lorsban claims and intellectual-property disputes remain material matters. The filing states that potential losses beyond recorded accruals may be material but cannot be estimated clearly for certain proceedings.
- Operating and market risks: Weather and climate, channel inventory, commodity and input costs, foreign exchange (including Argentina), customer credit, competition, regulatory approval timelines, third-party supply/licensing dependencies and geopolitical disruption may affect results.
- Other exposures: Pension and OPEB obligations, separation-related indemnities and taxes, cyber and supply-chain disruption, and sustainability commitments carry risks. Management reported no known cybersecurity incident with a material impact to date.
Most important facts for investors to verify
- Track 2024 sales, volume and channel inventory trends, particularly the pace of Crop Protection destocking recovery and Seed pricing/mix.
- Compare reported results with 2024 guidance, including cash conversion and the assumptions underlying non-GAAP Operating EBITDA, Operating EPS and free cash flow.
- Monitor the final status and opt-out outcome of the Nationwide Water District Settlement, other PFAS matters, remediation accruals and related indemnification recoveries.
- Assess restructuring execution, cash charges and whether the projected $100 million annualized savings by 2025 are achieved.
- Review debt, interest expense, seasonal working-capital needs, credit availability and planned shareholder returns alongside acquisition integration and returns.
- Consider the distinction between GAAP results and non-GAAP measures; the filing’s 2023 GAAP earnings include significant restructuring, foreign-exchange, settlement and discontinued-operations effects.